Pnc Financial Services Group, Inc. Novavax Inc Transaction History

Pnc Financial Services Group, Inc.

$162 Billion
Q3 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Novavax Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 545 shares of NVAX stock, worth $3,798. This represents 0.0% of its overall portfolio holdings.

Number of Shares

545

Previous 392 39.03%

Holding current value

$3,798

Previous $2,000 100.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$6.56 - $9.71 $1,003 - $1,485	153 Added 39.03%	545 $4,000
Q2 2025 Aug 08, 2025	SELL	$5.43 - $7.74 $7,411 - $10,565	-1,365 Reduced 77.69%	392 $2,000
Q1 2025 May 09, 2025	BUY	$6.41 - $10.82 $102 - $173	16 Added 0.92%	1,757 $11,000
Q4 2024 Feb 07, 2025	SELL	$7.22 - $14.68 $12,057 - $24,515	-1,670 Reduced 48.96%	1,741 $13,000
Q3 2024 Nov 08, 2024	SELL	$10.71 - $17.11 $4,444 - $7,100	-415 Reduced 10.85%	3,411 $43,000

Q2 2024 Aug 09, 2024	SELL	$3.89 - $20.97 $1,987 - $10,715	-511 Reduced 11.78%	3,826 $48,000
Q1 2024 May 10, 2024	BUY	$3.76 - $6.02 $3,568 - $5,712	949 Added 28.01%	4,337 $20,000
Q4 2023 Feb 09, 2024	BUY	$4.8 - $7.67 $4,723 - $7,547	984 Added 40.93%	3,388 $16,000
Q3 2023 Nov 13, 2023	BUY	$6.81 - $9.74 $8,240 - $11,785	1,210 Added 101.34%	2,404 $17,000
Q2 2023 Aug 11, 2023	BUY	$6.67 - $9.52 $4,608 - $6,578	691 Added 137.38%	1,194 $8,000
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $483 - $1,048	84 Added 20.05%	503 $3,000
Q4 2022 Feb 10, 2023	SELL	$8.86 - $25.04 $2,356 - $6,660	-266 Reduced 38.83%	419 $4,000
Q3 2022 Nov 10, 2022	SELL	$18.2 - $76.12 $1,456 - $6,089	-80 Reduced 10.46%	685 $12,000
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $5,768 - $11,971	-159 Reduced 17.21%	765 $39,000
Q1 2022 May 12, 2022	SELL	$69.73 - $142.9 $14,922 - $30,580	-214 Reduced 18.8%	924 $68,000
Q4 2021 Feb 11, 2022	SELL	$134.56 - $217.97 $69,971 - $113,344	-520 Reduced 31.36%	1,138 $162,000
Q3 2021 Nov 05, 2021	SELL	$177.8 - $270.58 $13,868 - $21,105	-78 Reduced 4.49%	1,658 $343,000
Q2 2021 Aug 06, 2021	BUY	$121.0 - $257.67 $62,678 - $133,473	518 Added 42.53%	1,736 $368,000
Q1 2021 May 07, 2021	BUY	$112.98 - $319.93 $34,571 - $97,898	306 Added 33.55%	1,218 $220,000
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $9,448 - $16,740	120 Added 15.15%	912 $101,000
Q3 2020 Nov 06, 2020	BUY	$79.44 - $178.51 $5,322 - $11,960	67 Added 9.24%	792 $85,000
Q2 2020 Aug 07, 2020	BUY	$13.86 - $83.61 $6,930 - $41,805	500 Added 222.22%	725 $60,000
Q1 2020 May 08, 2020	BUY	$3.93 - $16.0 $844 - $3,440	215 Added 2150.0%	225 $3,000
Q4 2019 Feb 07, 2020	BUY	$3.69 - $5.22 $36 - $52	10 New	10 $0

Others Institutions Holding NVAX

# of Institutions

307

Shares Held

100M

Call Options Held

5.7M

Put Options Held

9.03M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $545M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Novavax Inc Transaction History